GO:0046914 transition metal ion binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046914 (transition metal ion binding) is a molecular function describing the binding of transition metal ions such as iron, copper, zinc, manganese, cobalt, nickel, and molybdenum to proteins or other biomolecules.
• Transition metal binding is essential for protein stability, catalysis, electron transfer, and signal transduction, and it often involves coordination by histidine, cysteine, aspartate, and glutamate residues.
• Metal binding can induce local unfolding or destabilization of proteins, as shown for human carbonic anhydrase II.
• Dysregulated transition metal ion binding is implicated in Alzheimer's disease, cancer, and other pathologies.
• Key experimental approaches include isothermal titration calorimetry, FRET-based probes, computational chemistry, and CRISPR-based gene editing.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to study transition metal ion binding proteins.
Description
Transition metal ion binding (GO:0046914) is a fundamental molecular function that underpins numerous biological processes, from enzymatic catalysis to signal transduction. Transition metals, defined by their incomplete d-subshell, include essential elements such as iron, copper, zinc, manganese, and cobalt, which are indispensable for life. Proteins that bind these metals often use them as cofactors to stabilize structure, facilitate electron transfer, or catalyze chemical reactions. Understanding the mechanisms and specificity of transition metal ion binding is crucial for deciphering cellular physiology and developing therapeutic interventions. This article provides a comprehensive overview of the GO term, its biological significance, key genes, disease associations, and research methodologies, with a focus on CRISPR-based approaches for functional studies.
transition metal ion binding At A Glance
| GO ID | GO:0046914 |
|---|---|
| GO term | transition metal ion binding |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Binding to transition metal ions such as iron, copper, zinc, manganese, cobalt, nickel, molybdenum, and silver |
| Biologically relevant metals | Vanadium, manganese, iron, copper, cobalt, nickel, molybdenum, silver |
| Definition source | QuickGO |
| Related processes | Enzymatic catalysis, electron transport, protein stability, signal transduction |
What Is GO:0046914?
GO:0046914 (transition metal ion binding) is defined as the binding to a transition metal ion, which is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum, and silver. This molecular function is essential for many proteins that require metal ions for their activity, stability, or regulation.
Why Is transition metal ion binding Important in Cell Biology?
Transition metal ion binding is critical for a vast array of biological processes, including respiration, photosynthesis, DNA repair, and neurotransmission. Many enzymes, such as carbonic anhydrase and superoxide dismutase, depend on transition metals for catalysis. Dysregulation of metal binding is linked to diseases such as Alzheimer's disease, where copper and zinc interact with amyloid-beta peptides, and cancer, where metal complexes exhibit anti-cancer properties. Therefore, studying transition metal ion binding is essential for understanding fundamental biology and developing new therapies.
• Enables catalytic activity of metalloenzymes involved in metabolism and detoxification.
• Facilitates electron transfer in respiratory and photosynthetic chains.
• Maintains protein structure and stability through metal coordination.
• Regulates gene expression via metal-responsive transcription factors.
• Implicated in neurodegenerative diseases like Alzheimer's through metal-amyloid interactions.
• Target for anti-cancer drug development using transition metal complexes.
• Involved in immune response and host-pathogen interactions.
• Essential for biosynthesis of cofactors like heme and iron-sulfur clusters.
• Provides a basis for designing metal-based probes and therapeutics.
• Offers insights into evolutionary adaptation of proteins to metal availability.
Molecular Mechanism of transition metal ion binding
Metal Coordination Chemistry
In simple terms: Metals stick to proteins through special atoms that hold them in place.
Transition metal ions bind to proteins via coordination bonds with electron-donating atoms, typically nitrogen, oxygen, or sulfur from amino acid side chains such as histidine, cysteine, aspartate, and glutamate. The geometry and strength of these bonds depend on the metal's oxidation state and the protein's local environment. For example, copper(II) binding to amyloid-beta involves histidine coordination, as studied by FRET-based probes. Metal ion selectivity is governed by factors like the Irving-Williams series and protein architecture.
Thermodynamics and Kinetics of Binding
In simple terms: How tightly and how fast a metal binds to a protein can be measured.
The binding affinity and kinetics of transition metal ions to proteins are determined by thermodynamic parameters such as dissociation constants (Kd) and enthalpy/entropy changes. Isothermal titration calorimetry (ITC) and computational methods have been used to quantify these interactions, revealing that metal binding can be coupled to protein conformational changes. For instance, metal ion binding to human carbonic anhydrase II induces local unfolding and destabilization, highlighting the dynamic nature of these interactions.
Structural Consequences of Metal Binding
In simple terms: When a metal binds, it can change the shape of the protein.
Metal binding often triggers conformational changes that can stabilize or destabilize protein structure. In some cases, metal binding leads to local unfolding, as observed in carbonic anhydrase II. Conversely, metal coordination can rigidify flexible loops, as seen in disordered amyloid-beta peptides upon copper binding. These structural effects are critical for protein function and are studied using techniques like NMR, X-ray crystallography, and FRET.
Metal Homeostasis and Regulation
In simple terms: Cells control how much metal is available and where it goes.
Transition metal ion binding is regulated by metal homeostasis networks involving transporters, chaperones, and metalloregulatory proteins. For example, iron availability influences the expression of iron-binding proteins, as discussed in the context of iron as life's primeval transition metal. Metal-responsive transcription factors sense intracellular metal levels and modulate gene expression to maintain balance. Disruption of this regulation can lead to metal overload or deficiency, contributing to disease.
Evolutionary and Functional Diversity
In simple terms: Different organisms use metals in various ways to survive.
Transition metal ion binding proteins have evolved diverse functions across all domains of life. A trimeric beta-gamma-crystallin from a thermophilic archaeon binds transition metals, illustrating adaptation to extreme environments. The ancient availability of iron shaped early life, as iron is considered life's primeval transition metal. This evolutionary perspective helps understand metal usage in modern organisms and informs biotechnological applications.
Key Genes Involved in GO:0046914 transition metal ion binding
The following genes encode proteins that bind transition metal ions and are representative of the diverse functions associated with GO:0046914.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CA2 | Zinc-binding carbonic anhydrase; catalyzes CO2 hydration | Metal-induced unfolding studied by McConnell et al. |
| APP | Amyloid precursor protein; binds copper and zinc | Implicated in Alzheimer's disease; metal binding studied by Wu et al. |
| SOD1 | Copper-zinc superoxide dismutase; antioxidant defense | Mutations linked to ALS; metal binding essential for activity |
| MT1A | Metallothionein; binds zinc and copper for detoxification | Regulates metal homeostasis and oxidative stress |
| FTH1 | Ferritin heavy chain; iron storage | Key for iron metabolism; studied in cancer and neurodegeneration |
| FTL | Ferritin light chain; iron storage | Mutations cause ferritinopathy; iron binding critical |
| TFRC | Transferrin receptor; iron uptake | Target for cancer therapy; regulates iron influx |
| CP | Ceruloplasmin; copper transport | Copper metabolism; linked to Wilson's disease |
| ATP7A | Copper-transporting ATPase | Mutations cause Menkes disease |
| ATP7B | Copper-transporting ATPase | Mutations cause Wilson's disease |
| SLC11A1 | Divalent metal transporter; iron and manganese transport | Host defense; associated with infectious diseases |
| HMOX1 | Heme oxygenase; releases iron from heme | Cytoprotective; studied in inflammation |
| ALAD | Zinc-dependent aminolevulinate dehydratase; heme synthesis | Inhibited by lead; relevant to porphyria |
| MMP2 | Zinc-dependent matrix metalloproteinase | Cancer invasion and metastasis |
| NOS2 | Heme-containing nitric oxide synthase | Inflammation and cancer |
| CYP3A4 | Heme-containing cytochrome P450 | Drug metabolism; iron binding essential |
| PRNP | Prion protein; binds copper | Neurodegeneration; metal binding modulates aggregation |
| B2M | Beta-2-microglobulin; binds iron | Amyloidosis; metal binding studied |
How Is transition metal ion binding Regulated?
Transition metal ion binding is regulated at multiple levels, including metal availability, protein expression, and post-translational modifications. Metal-responsive transcription factors such as MTF1 (metal regulatory transcription factor 1) sense zinc and other metals and activate genes involved in metal homeostasis. Iron regulatory proteins (IRP1 and IRP2) control the translation of ferritin and transferrin receptor mRNAs in response to iron levels. Additionally, metal chaperones deliver metals to specific target proteins, ensuring proper metallation. Dysregulation of these pathways can lead to metal imbalance and disease.
transition metal ion binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APP | Alzheimer's disease; metal-induced aggregation | Knockout or point mutation in APP; FRET-based metal binding assays |
| SOD1 | Amyotrophic lateral sclerosis; metal binding mutations | Knock-in of SOD1 mutations; metal binding and activity assays |
| ATP7B | Wilson's disease; copper transport defect | Knockout of ATP7B in hepatocytes; copper accumulation studies |
| FTH1 | Neurodegeneration with brain iron accumulation | Knockout or overexpression; iron storage and oxidative stress assays |
| MMP2 | Cancer invasion and metastasis | Knockout in cancer cell lines; invasion assays and metal binding studies |
Alzheimer's Disease
Transition metal ion binding, particularly copper and zinc binding to amyloid-beta (Aβ), is implicated in Alzheimer's disease pathogenesis. Cu(II)-mediated Aβ ligand binding has been studied using FRET-based probes, revealing that metal interactions promote Aβ aggregation and oxidative stress. Computational studies have provided insights into the structural and dynamic aspects of metal-Aβ interactions, highlighting their role in neurodegeneration.
Cancer
Transition metal complexes have shown anti-cancer properties through DNA binding and interaction with cellular targets. A decade update on first-row transition metal complexes highlights their potential as anticancer agents, with mechanisms involving DNA intercalation, cleavage, and inhibition of topoisomerases. Metal-binding proteins such as matrix metalloproteinases (MMPs) are also targets for cancer therapy due to their role in invasion and metastasis.
Metal Metabolism Disorders
Disorders of copper metabolism, such as Wilson's disease and Menkes disease, result from mutations in copper-transporting ATPases (ATP7B and ATP7A). These proteins bind copper and are essential for its distribution. Iron overload disorders, such as hemochromatosis, involve dysregulated iron binding and storage. Understanding transition metal ion binding is crucial for diagnosing and treating these conditions.
From transition metal ion binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene bind transition metals? | Overexpression with affinity tag; metal binding assays (ITC, FRET) |
| What is the effect of a disease-associated point mutation on metal binding? | Point mutation knock-in using CRISPR; compare binding affinity and structure |
| Is the metal-binding domain essential for protein function? | Knockout of the domain or full gene; functional assays |
| How does metal binding affect protein stability? | Tagged knock-in for FRET or NMR; stability measurements |
| Can we screen for genes regulating metal homeostasis? | CRISPR library screening with metal-responsive reporters |
| What is the role of metal binding in a specific tissue? | Tissue-specific knockout or overexpression in animal models |
How to Study the transition metal ion binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry (ITC) | Binding affinity, enthalpy, stoichiometry | Quantifying metal-protein interactions |
| FRET | Conformational changes, binding dynamics | Real-time detection of metal binding |
| NMR spectroscopy | Structural changes, metal coordination | Atomic-level characterization of metal binding sites |
| X-ray crystallography | 3D structure of metal-protein complexes | Determining coordination geometry |
| Molecular dynamics simulations | Binding energetics, dynamics | Modeling metal binding to flexible peptides |
| CRISPR knockout | Gene function loss | Identifying essential metal-binding proteins |
| CRISPR point mutation | Effect of specific amino acid changes | Dissecting metal-coordinating residues |
| CRISPR library screening | Phenotypic screening of many genes | Discovering regulators of metal homeostasis |
Biophysical Methods for Metal Binding
Isothermal titration calorimetry (ITC) measures thermodynamic parameters of metal binding, such as Kd and stoichiometry. FRET-based probes can detect metal-induced conformational changes in real time, as demonstrated for Cu(II)-Aβ interactions. NMR and X-ray crystallography provide atomic-level structural insights into metal coordination.
Computational Approaches
Molecular dynamics simulations and quantum mechanics/molecular mechanics (QM/MM) calculations model metal binding sites and predict binding affinities. Computational chemistry studies have elucidated the interactions of transition metals with disordered amyloid-beta peptides, offering mechanistic insights into Alzheimer's disease.
CRISPR-Based Functional Genomics
CRISPR knockout, point mutation, and knock-in models enable precise interrogation of genes involved in transition metal ion binding. For example, knocking out a metal-binding protein can reveal its role in metal homeostasis and disease. CRISPR library screening can identify novel regulators of metal metabolism.
Proteomic and Genomic Profiling
Mass spectrometry-based proteomics can identify metal-binding proteins and their post-translational modifications. RNA-seq and Ribo-seq reveal transcriptional and translational responses to metal stress. These methods are powerful for studying global changes in metal homeostasis.
How CRISPR Can Be Used to Study GO:0046914 transition metal ion binding
Knockout
CRISPR knockout (KO) of genes encoding transition metal-binding proteins allows researchers to study loss-of-function phenotypes. For example, knocking out CA2 can reveal its role in pH regulation and metal binding. KO models are essential for validating gene function and identifying compensatory mechanisms.
Point Mutation
CRISPR point mutation introduces specific amino acid substitutions to dissect metal-coordinating residues. For instance, mutating histidine residues in amyloid-beta can abolish copper binding, providing insights into metal-induced aggregation. This approach is crucial for understanding the structural basis of metal binding.
Knock-in
CRISPR knock-in can insert tags (e.g., GFP, FRET pairs) or disease-associated mutations into endogenous loci. Tagged knock-in enables real-time imaging of metal binding in live cells. Disease mutation knock-in models, such as SOD1 mutations, are valuable for studying metal-related pathologies.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase levels of metal-binding proteins to study their effects on metal homeostasis and cellular physiology. Overexpression of ferritin, for example, can protect cells from iron-induced oxidative stress.
How EDITGENE Supports transition metal ion binding Research
Researchers studying transition metal ion binding-related genes often need to determine whether a candidate gene is causally involved in metal homeostasis, disease pathogenesis, or cellular responses to metal stress. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for transition metal ion binding research.
Frequently Asked Questions About transition metal ion binding
What is GO:0046914?
GO:0046914 is the Gene Ontology term for transition metal ion binding, a molecular function describing the binding to transition metal ions such as iron, copper, and zinc.
What genes are involved in transition metal ion binding?
Genes such as CA2, APP, SOD1, MT1A, FTH1, and ATP7B encode proteins that bind transition metals and are involved in various cellular processes.
How does transition metal ion binding affect protein structure?
Metal binding can stabilize or destabilize protein structure, sometimes inducing local unfolding, as seen in carbonic anhydrase II.
What diseases are associated with transition metal ion binding?
Alzheimer's disease, cancer, Wilson's disease, and Menkes disease are linked to dysregulated transition metal ion binding.
What methods are used to study transition metal ion binding?
Common methods include isothermal titration calorimetry, FRET, NMR, X-ray crystallography, and computational simulations.
How can CRISPR be used to study transition metal ion binding?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes encoding metal-binding proteins to study their function.
What is the role of copper in Alzheimer's disease?
Copper binds to amyloid-beta peptides, promoting aggregation and oxidative stress, which contribute to Alzheimer's pathology.
What are the biologically relevant transition metals?
Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum, and silver, as defined by GO:0046914.
How does metal ion selectivity work?
Metal ion selectivity is determined by the protein's coordination environment, including the type and geometry of coordinating residues, as well as thermodynamic preferences.
Can transition metal complexes be used as anticancer drugs?
Yes, first-row transition metal complexes have shown anti-cancer properties through DNA binding and other mechanisms, making them promising therapeutic agents.
Conclusion
Transition metal ion binding (GO:0046914) is a fundamental molecular function that impacts nearly every aspect of cellular life, from catalysis to signaling. Its dysregulation is implicated in major human diseases, including Alzheimer's disease and cancer. Advances in biophysical, computational, and CRISPR-based methods are providing unprecedented insights into the mechanisms and specificity of metal binding. EDITGENE's comprehensive CRISPR services empower researchers to dissect the roles of metal-binding proteins and accelerate the development of targeted therapies.
References
- 1. Wu R et al.. 2024. Transition Metal Ion FRET-Based Probe to Study Cu(II)-Mediated Amyloid-β Ligand Binding.. J Am Chem Soc 146(3):2102-2112 PMID: 38225538
- 2. Song LF et al.. 2020. Thermodynamics of Transition Metal Ion Binding to Proteins.. J Am Chem Soc 142(13):6365-6374 PMID: 32141296
- 3. McConnell KD et al.. 2022. Metal Ion Binding Induces Local Protein Unfolding and Destabilizes Human Carbonic Anhydrase II.. Inorg Chem 61(3):1249-1253 PMID: 34989562
- 4. Johnson JE et al.. 2024. Iron: Life's primeval transition metal.. Proc Natl Acad Sci U S A 121(38):e2318692121 PMID: 39250667
- 5. Strodel B et al.. 2019. Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer's Disease: Insights from Computational Chemistry Studies.. J Chem Inf Model 59(5):1782-1805 PMID: 30933519
- 6. Sóvágó I et al.. 2006. Metal ion selectivity of oligopeptides.. Dalton Trans PMID: 16896443
- 7. Dasmahapatra U et al.. 2024. Anti-cancer property and DNA binding interaction of first row transition metal complexes: A decade update.. Eur J Med Chem 275:116603 PMID: 38936150
- 8. Srivastava SS et al.. 2017. A Transition Metal-Binding, Trimeric βγ-Crystallin from Methane-Producing Thermophilic Archaea, Methanosaeta thermophila.. Biochemistry 56(9):1299-1310 PMID: 28029780
